6 completed, 2 active not recruiting, 1 recruiting, 1 suspended. 10 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 6, Active not recruiting 2, Recruiting 1, Suspended 1 |
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Suspended 1 |
Follow Carbidopa: new trials by email Literature Review of Carbidopa trials Research Report on Carbidopa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intestinal Levodopa + Entacapone Therapy (LecigonĀ®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease LECIG (levodopa, carbidopa, entacapone intestinal gel), Best oral medication - PARKINSON DISEASE (Disorder) | Phase 3 | Recruiting | University Hospital Tuebingen | 150 | 2025-10-27 | 2026-07-13 |
| Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease ABBV-951, Placebo for Levodopa/Carbidopa (LD/CD), Levodopa/Carbidopa (LD/CD) - Parkinson's Disease (PD) | Phase 3 | Completed | AbbVie | 174 | 2020-10-19 | 2022-11-18 |
| Effects of 5HTP on the Injured Human Spinal Cord 5-Hydroxytryptophan 100 MG, 5-Hydroxytryptophan, Carbidopa - Spinal Cord Injuries | Phase 2 / Phase 3 | Active not recruiting | University of Alberta | 6 | 2020-07-01 | 2026-09-16 |
| Effects of 5HTP and LDOPA on CNS Excitability After SCI 5HTP, L-DOPA, Placebo oral tablet - Spinal Cord Injuries | Phase 2 / Phase 3 | Suspended | Jessica M D'Amico | 30 | 2019-06-19 | 2022-10-17 |
| Enhancement of Stroke Rehabilitation With Levodopa IMP Levodopa 100mg/Carbidopa 25mg, Matching placebo - Acute Stroke, Stroke Rehabilitation | Phase 3 | Active not recruiting | University Hospital, Basel, Switzerland | 610 | 2019-06-14 | 2024-10-15 |
| A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER) Optimized antiparkinsonian treatment, Levodopa-Carbidopa Intestinal Gel (LCIG), CADD-Legacy ambulatory infusion pump - Parkinson's Disease (PD) | Phase 3 | Completed | AbbVie | 63 | 2017-02-09 | 2020-08-18 |
| Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon BIA 9-1067, Entacapone, Placebo - Parkinson's Disease | Phase 3 | Completed | Bial - Portela C S.A. | 600 | 2011-03-01 | 2015-09-18 |
| Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. BIA 9-1067, Placebo, Levodopa - Parkinson's Disease | Phase 3 | Completed | Bial - Portela C S.A. | 427 | 2011-03-01 | 2015-10-19 |
| Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia Carbidopa, Placebo - Familial Dysautonomia | Phase 3 | Completed | NYU Langone Health | 12 | 2009-12-01 | 2016-03-28 |
| Peripheral Dopamine in Postural Tachycardia Syndrome Carbidopa, Placebo - Postural Tachycardia Syndrome, Orthostatic Intolerance | Phase 2 / Phase 3 | Completed | Vanderbilt University | 32 | 2008-05-01 | 2022-01-24 |
Parkinson Disease (5) · Spinal Cord Injuries (2) · Disruptive, Impulse Control, and Conduct Disorders (1) · Dysautonomia, Familial (1) · Ischemic Stroke (1) · Orthostatic Intolerance (1) · Postural Orthostatic Tachycardia Syndrome (1) · Stroke (1)
AbbVie (2) · Bial - Portela C S.A. (2) · Jessica M D'Amico (1) · NYU Langone Health (1) · University Hospital Tuebingen (1) · University Hospital, Basel, Switzerland (1) · University of Alberta (1) · Vanderbilt University (1)
United States (5) · Portugal (2) · Australia (1) · Canada (1) · Finland (1) · Germany (1) · Greece (1) · Hungary (1) · Italy (1) · Slovakia (1) · Spain (1) · Switzerland (1)
Jessica D'Amico, PhD (2) · Alfredo J Gamboa, MD (1) · Horacio C Kaufmann, M.D. (1) · Joaquim Ferreira, MD, PhD (1) · Stefan Engelter, Prof. MD (1)
PMID 26725544, PMID 28027332, PMID 34236101, PMID 36402160, PMID 38345741, PMID 40979212, PMID 40982270, PMID 41045349, PMID 41324738, PMID 41701756, PMID 42525438
2016 (1), 2018 (1), 2019 (1), 2025 (1)